top of page

Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

CJC-1295 with DAC 5mg

CJC-1295 with DAC 5mg

$115.00Price
Quantity
Quantity

CJC-1295 with DAC 5mg – Research Peptide

Product OverviewCJC-1295 with DAC is a modified version of a growth hormone-releasing hormone (GHRH) analog, designed with added stability and extended activity for research purposes. It includes a Drug Affinity Complex (DAC), which allows the peptide to bind to serum albumin and remain active for longer periods in experimental models. This makes it useful for studying prolonged growth hormone signaling in both cell-based and animal research. Supplied as a lyophilized powder in 2mg vials.

Mechanism of ActionIn laboratory settings, CJC-1295 works by activating GHRH receptors, which play a role in regulating growth hormone release. The DAC component helps extend the peptide’s presence by binding to albumin, allowing researchers to examine longer-lasting signaling effects compared to shorter-acting compounds. This makes it suitable for studying sustained versus pulsatile hormone activity under controlled conditions.

Research BackgroundStudies such as Teichman et al. (2006) have explored the pharmacology and stability of CJC-1295 with DAC, highlighting its resistance to enzymatic breakdown and extended duration of action. Additional preclinical research supports its ability to maintain elevated activity levels over time, making it valuable for long-acting peptide investigations.

Product Specifications & Storage

  • Form: White lyophilized powder

  • Quantity: 2mg per vial

  • Storage: Store at -20°C in a sealed, dry environment

  • Reconstitution: Use sterile saline or bacteriostatic water

  • Shelf life: Up to 36 months when stored properly

  • Purity: >99% (HPLC tested)

  • Approx. molecular weight: ~3.5 kDa (including DAC)

DisclaimerFor research use only. Not intended for human consumption, medical use, or therapeutic applications. All information is based on preclinical studies. Proper regulatory approval is required for laboratory use.

    bottom of page